3rd Beijing International Medical Health Innovation Exhibition 2018

Beijing National Convention Center
Beijing National Convention Center

 

To promote medical industry upgrading, to implement innovation-driven strategies and to enhance the technology and innovation capacity of medical industry, Beijing Pharmaceutical Profession Association will hold IMHI 2018 (3rd Beijing International Medical Health Innovation Exhibition 2018), formerly named as Beijing International Biomedical Innovation Exhibition. The year 2018 marks the 40th anniversary of China's reform and opening up. This year’s exhibition will also center on Open, Innovative and Upgrading, presenting medical and health achievements during these four decades that cover a wide range of product and technology innovations such as chemicals, biopharmaceuticals, modern TCMs, herbal medicine slices, medicine R&D, pharmaceutical services.

 

2nd Beijing International Biomedical Innovation Exhibition with an exhibition size of 10,000 square meters received the participation of over 6,000 professional visitors and more than 200 exhibitors from 26 provinces and municipalities. Exhibitors include but not limit to: Tongrentang, Youcare Pharmaceutical, Yabao Pharmaceutical, CR Double-Crane, Asia-East Bio-pharmaceutical, Beijing Konruns Pharmaceutical, Jialin Pharmaceutical, Science Sun, Tide Pharm, Kelun Pharm, Yangtze River Pharmaceutical, Minhai Biotechnology, Bayer, Sanofi, GSK China, Novartis China.

 

IMHI2018 will hold a series of summits, roadshows and promotions focusing on policy interpretation, industry analysis, cutting-edge technology and product promotion. This year, specific academic conferences and forums are arranged to enhance cooperation and exchange between hospitals and enterprises. This year also create an opportunity to explore hospital-enterprise collaborative development under the backdrop of intensive economic transformation and medical reform. Meanwhile, IMHI2018 attracts full engagement of distributors and agents and creates a platform for trade and information exchange. 

 

IMHI2018 Guiding Organizations:

Beijing Municipal Development and Reform Commission, Beijing Municipal Commission of Economy and Information Technology, Beijing Municipal Science and Technology Commission, Beijing Food and Drug Administration, Beijing Municipal Commission of Health and Family Planning, Beijing Municipal Administration of Hospitals, Beijing Municipal Administration of Traditional Chinese Medicine Hospitals, Administrative Committee of Z-Park.

 

IMHI2018 Support Organizations:

Chinese Center for Disease Control and Prevention, China Association of Pharmaceutical Commerce, China Association of Traditional Chinese Medicine, China Nonprescription Medicines Association, China Association of Geriatric Research, China Pharmaceutical Technology Transfer Center, PSM China, Beijing Municipal Science and Technology Center of New Medicine, Beijing Technology Market Association, Tianjin Municipal Pharmaceutical Professional Association, Hebei Provincial Pharmaceutical Professional Association, Hainan Provincial Pharmaceutical Professional Association, Lanzhou Municipal Pharmaceutical Professional Association, Sichuan Provincial Pharmaceutical Professional Association, Fujian Provincial Pharmaceutical Professional Association, Beijing Green and New Technology Alliance, Beijing Pharmacists Association, Beijing Medical Doctor Association.

IMHI2018 Academic Support Organizations:

Capital Medical University, School of Pharmaceutical Sciences of Tsinghua University, Beijing Medical Association, Beijing Pharmaceutical Association, Beijing Association of Chinese Medicine.

 

IMHI2018 Sponsor:

Beijing Pharmaceutical Profession Association

 

IMHI2018 Co-sponsors:

Beijing Economic Technological Development Area, Administrative Committee of Daixing Biopharmaceutical Production Base of Z-Park Nation Independent Innovation Demonstration Zone, Changping Health Industry Alliance of Z-Park.

 

IMHI2018 Organizer:

Beijing Qianfan International Exhibition Service Co. Ltd.

 

Visitor Resources:

Hospitals, clinicians, pharmacists, distributors, agents, pharmacies, retailers, research institutes, pharmaceutical enterprises, community clinics, etc.

 

IGeneral Information

Theme: Open, Innovative, Upgrading

Date: October 29-31, 2018

Venue: Beijing National Convention Center

Address: No.7, Tianchen East Rd., Chaoyang District, Beijing

Exhibition Area: 13,000 square meters

IIExhibition Category:

Medicine: chemicals, modern TCMs, OTCs, antibody engineering medicines, vaccines, antibiotics, antitumor drugs, pediatric drugs, pharmaceutic adjuvants, biological products, protein drugs, genetic drugs, biochips, nanotechnology drugs.

 

Industry Technology and Service Area: research institutes, pharmaceutical engineering design, incubators, industrial parks, science and technology transfer, CRO, medical technology counseling, financial services, etc.

 

III. Exhibition Fees

 Unit: RMB

International Standard Booth                               19,800/9㎡

Raw Space                                                           1,830/㎡

Domestic Standard Booth

  • First Class                                                 13,800/9㎡
  • Second Class                                            11,800/9㎡

Raw Space                                                           1,180/㎡

Note:

Standard Booth (3M×3M) Setups: fascia board, theme board, table and desk, 6 chairs, 2 spotlights, socket, dustbin, covering carpet. Registration, exhibition guidebook and exhibitor badge are included. Extra 20% charge for corner booths.

 

IV. Activities

China Pharmaceutical Secretary-General Conference

Beijing International Biomedical Innovation Exhibition and Summit

Beijing Biomedical Achievement Display and Promotion

3rd Vaccine Industry Summit

Chinese Medicine and Health Industry Summit

Oncology: Treatment and Diagnosis

Pediatric Medication Safety Forum

 

IMHI2018 will also organize special events and forums on conformity assessment, two-vote system, drug distribution, medical insurance catalog, investment and financing of medical and health industry. Please stay tuned.